Related Experiment Video
Updated: Jun 12, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Insulin pump use in adults with type 1 diabetes--practical issues
Greeshma Shetty1, Howard Wolpert
1Section of Adult Diabetes, Joslin Diabetes Center, One Joslin Place, Boston, MA 02215, USA.
Diabetes Technology & Therapeutics
|June 3, 2010
Summary
Continuous subcutaneous insulin infusion pumps are widely used for type 1 diabetes. This review covers practical aspects of insulin pump therapy, including benefits, risks, and managing glucose control.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Diabetes Management
Background:
- Continuous subcutaneous insulin infusion (CSII) pumps are increasingly adopted for type 1 diabetes (T1D) management in adults.
- Pump therapy offers an alternative to multiple daily injections (MDI) for T1D patients.
- Practical considerations in CSII therapy are crucial for effective patient care.
Purpose of the Study:
- To review key practical aspects of insulin pump therapy for type 1 diabetes.
- To discuss benefits and risks associated with insulin pump use.
- To provide guidance on managing common challenges in pump therapy.
Main Methods:
- Literature review focusing on clinical experience and established practices in insulin pump therapy.
- Analysis of benefits and risks, including hypoglycemia prevention.
- Discussion of patient selection criteria comparing pump therapy to MDI.
- Identification of pump-specific causes of glucose variability and detection strategies.
- Evaluation of different bolus types for mealtime insulin coverage.
Main Results:
- Insulin pump therapy offers significant benefits but also carries risks, including hypoglycemia.
- Patient-specific factors influence the choice between pump therapy and MDI.
- Erratic glucose control can stem from pump-related issues, detectable through routine practices.
- Appropriate use of various bolus types is essential for prandial glucose management.
Conclusions:
- Insulin pump therapy requires careful management of practical issues for optimal outcomes in type 1 diabetes.
- Understanding pump-specific challenges and employing appropriate strategies can improve glucose control and safety.
- Individualized patient care is paramount when selecting and managing insulin pump therapy.
Related Concept Videos
01:16Insulin: Dosing Regimen and Adverse Effects
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
01:27Insulin Formulations: Types and Delivery
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Short-acting insulins are divided into rapid-acting...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...